select trial glp 1 glp-1 Semaglutide and the Heart: clinical insights from the SGLTi and GLP-1 in HF – Efficacy of GLP‐1 Receptor Agonist‐Based

Copper signaling is believed to play a role in GHK-Cus biological activity, and a specific level of copper is required for stem cells to function correctly [5]

Henry Meds is a telehealth provider offering treatments for weight loss and low testosterone

GLP-1 RAs STEP 1 (2021) : Semaglutide 2.4 ./ 14.9% 68 2.4% (Wilding et al., 2021, NEJM) SURMOUNT-1 (2022) : Tirzepatide (GLP-1/GIP dual agonist) 15 ./ 20.9% (Jastreboff et al., 2022, NEJM) GLP-1 HbA1c () 2 (Hypoglycemia) Glucose-dependent LEADER (liraglutide) SUSTAIN-6 (semaglutide) 2024 FDA Semaglutide (Wegovy) FLOW (2024) semaglutide (MASLD/NAFLD) GLP-1 RAs GLP-1

Protect from direct sunlight or extreme temperatures

It is a biochemically rational protocol built on two peptides that address different phases of the same healing process